Skip to main navigation

Top

Skip to main content

About Us

About Us
Rare Diseases

Rare Defined Diseases
Pipeline

Pipeline
Our Medicine

Our Medicine
Patients & Partners

Patients & Partners
Investors

Investors
Inside Agios

Inside Agios

Press Releases

Investors Overview
News & Events
Stock Information
Corporate Governance
Financials
IR Resources

Year

Feb 23, 2023

Agios Reports Fourth Quarter and Full Year 2022 Financial Results

Read More

PDF Version

Feb 02, 2023

Agios to Webcast Conference Call of Fourth Quarter and Year End 2022 Financial Results on Feb. 23, 2023

Read More

PDF Version

Jan 08, 2023

Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company’s Vision to Transform Patient Outcomes in Rare Diseases

Read More

PDF Version

Jan 03, 2023

Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer

Read More

PDF Version

Pagination

First page
Previous page
Page 1
Current page 2

Displaying 11 - 14 of 14

Latest Earnings Call View Replay
Latest Form 10-K View PDF
Email Alerts Sign Up
Corporate Fact Sheet View PDF
Corporate Responsibility View PDF

Connect with us on LinkedIn or follow us on Twitter as we push forward into changing the landscape for people with genetically defined diseases.

Connect on LinkedIn

Follow us our Twitter

Contact
About Us
Partner Opportunities
Careers

Agios Pharmaceuticals, Inc. © 2023

All right reserved.

Cookies Preferences
Copyright Info
Compliance
Sitemap
Privacy Notice
Terms of Use